Respiratory tract infections and the fluoroquinolones of the latest generations

This article presents data for the etiology of pneumonia and exacerbations of chronic bronchitis/chronic obstructive pulmonary disease. The spectrum of respiratory fluoroquinolones (levofloxacin, moxifloxacin), indications for their use, treatment regimens and dosage regimens are considered. The author presents own data for the long-term use of levofloxacin in the treatment of lower respiratory tract infections. Various schemes of levofloxacin use, including step-down therapy are expressed. The effectiveness of levofloxacin alone and in combination with carbapenems in the treatment of critically severe pneumonia is presented.

lower respiratory tract infection, pneumonia, chronic obstructive pulmonary disease, respiratory fluoroquinolones, levofloxacin